These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8615560)

  • 21. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
    Opal SM; Palardy JE; Parejo N; Morrison DC
    J Endotoxin Res; 2001; 7(1):35-8. PubMed ID: 11521079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal therapy for bacteremia and sepsis.
    Guglielmo J; Wiener-Kronish JP
    West J Med; 1992 Aug; 157(2):174. PubMed ID: 1441476
    [No Abstract]   [Full Text] [Related]  

  • 24. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
    Wang Z; Su F; Rogiers P; Vincent JL
    Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
    Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
    J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic strategies in cases of septicemia caused by gram-negative bacteria].
    Łukasiewicz J; Ługowski C
    Postepy Hig Med Dosw; 2003; 57(3):251-62. PubMed ID: 14524245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur.
    Netea MG; Demacker PN; Kullberg BJ; Jacobs LE; Verver-Jansen TJ; Boerman OC; Stalenhoef AF; Van der Meer JW
    Cytokine; 1998 Oct; 10(10):766-72. PubMed ID: 9811529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoprotein prevents organ damage in endotoxemia.
    Lee RP; Lin NT; Chao YF; Lin CC; Harn HJ; Chen HI
    Res Nurs Health; 2007 Jun; 30(3):250-60. PubMed ID: 17514720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of endotoxic shock.
    Villa P; Ghezzi P
    Methods Mol Med; 2004; 98():199-206. PubMed ID: 15064441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
    JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
    BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
    Pajkrt D; Doran JE; Koster F; Lerch PG; Arnet B; van der Poll T; ten Cate JW; van Deventer SJ
    J Exp Med; 1996 Nov; 184(5):1601-8. PubMed ID: 8920850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.